Ovarian Cancer Survival Differs by Race

November 26, 2018

Older women who are not white are less likely to receive optimal treatment for ovarian cancer and more likely to die compared with older women who are white, according to a study published in the November 2018 issue of Gynecologic Oncology.

Researchers came to their finding after identifying 9016 women age 66 and older with advanced ovarian cancer in a Medicare databased linked to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. All of the women were diagnosed between 2002 and 2011. Among the study population, 2638 received primary chemotherapy, 4854 received primary surgery, and 1524 received no treatment.

Some 57.2% of women who were white received both chemotherapy and surgery compared with 39.9% of women who were black, 48.9% of women who were Hispanic, and 54.2% of women who were another race/ethnicity, researchers reported. Receiving only surgery or only chemotherapy—or neither—was linked with higher risk of death compared with receiving both surgery and chemotherapy.

Being black was significantly correlated with worse overall survival, the study found.

Jolynn Tumolo

For articles by First Report Managed Care, click here

To view the First Report Managed Care print issue, click here